[HTML][HTML] A comparative study of the safety and efficacy between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the management of …
TS Peresuodei, A Gill, C Orji, M Reghefaoui… - Cureus, 2024 - ncbi.nlm.nih.gov
Renin-angiotensin-aldosterone system (RAAS) inhibitors, including angiotensin-converting
enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs), are commonly used in …
enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs), are commonly used in …
Should angiotensin-converting enzyme inhibitors ever be used for the management of hypertension?
JM Turner, R Kodali - Current Cardiology Reports, 2020 - Springer
Abstract Purpose of Review Angiotensin-converting enzyme inhibitors and angiotensin
receptor blockers are commonly used anti-hypertensive medications in a number of clinical …
receptor blockers are commonly used anti-hypertensive medications in a number of clinical …
Comparative effectiveness of angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers for hypertension on clinical end points: a cohort study
J Clin Hypertens (Greenwich). 2012; 14: 407–414.© 2012 Wiley Periodicals, Inc. Important
questions concerning the comparative effectiveness of angiotensin‐converting enzyme …
questions concerning the comparative effectiveness of angiotensin‐converting enzyme …
Choosing among renin-angiotensin system blockers for the management of hypertension: from pharmacology to clinical efficacy
JM Neutel - Current medical research and opinion, 2010 - Taylor & Francis
Background: Hypertension is an important healthcare challenge, yet despite initiatives to
improve detection and advances in therapy, the majority of patients do not achieve …
improve detection and advances in therapy, the majority of patients do not achieve …
Angiotensin-converting enzyme inhibitors in hypertension: to use or not to use?
FH Messerli, S Bangalore, C Bavishi… - Journal of the American …, 2018 - jacc.org
Most guidelines for the management of patients with cardiovascular disease recommend
angiotensin-converting enzyme (ACE) inhibitors as first-choice therapy, whereas …
angiotensin-converting enzyme (ACE) inhibitors as first-choice therapy, whereas …
A systematic review and network meta-analysis of the comparative efficacy of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in …
C Dimou, C Antza, E Akrivos, I Doundoulakis… - Journal of Human …, 2019 - nature.com
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers are drugs
commonly used for the treatment of hypertension. However, studies on their comparative …
commonly used for the treatment of hypertension. However, studies on their comparative …
Comparative first-line effectiveness and safety of ACE (angiotensin-converting enzyme) inhibitors and angiotensin receptor blockers: a multinational cohort study
ACE (angiotensin-converting enzyme) inhibitors and angiotensin receptor blockers (ARBs)
are equally guideline-recommended first-line treatments for hypertension, yet few head-to …
are equally guideline-recommended first-line treatments for hypertension, yet few head-to …
Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension
DB Matchar, DC McCrory, LA Orlando… - Annals of internal …, 2008 - acpjournals.org
Background: The relative effectiveness of angiotensin-converting enzyme (ACE) inhibitors
and angiotensin II receptor blockers (ARBs) for lowering blood pressure is unknown …
and angiotensin II receptor blockers (ARBs) for lowering blood pressure is unknown …
The pivotal role of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in hypertension management and cardiovascular and renal …
LA Alcocer, A Bryce, D De Padua Brasil, J Lara… - American Journal of …, 2023 - Springer
Arterial hypertension is the main preventable cause of premature mortality worldwide.
Across Latin America, hypertension has an estimated prevalence of 25.5–52.5%, although …
Across Latin America, hypertension has an estimated prevalence of 25.5–52.5%, although …
Angiotensin-Converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers
B Tazkarji, A Ganeshamoorthy, B Auten - American Family Physician, 2015 - aafp.org
Angiotensin-Converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers | AAFP
Advertisement search close brand logo BACHIR TAZKARJI, MD, AND AMBIKA …
Advertisement search close brand logo BACHIR TAZKARJI, MD, AND AMBIKA …